panobinostat
Showing 1 - 25 of 149
Melanoma, Skin Cancer Trial in Tampa (Panobinostat, Ipilimumab)
Completed
- Melanoma
- Skin Cancer
- Panobinostat
- Ipilimumab
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jan 18, 2023
Diffuse Intrinsic Pontine Glioma, Pediatric Brainstem Glioma, Pediatric Brainstem Gliosarcoma, Recurrent Trial in Boston
Active, not recruiting
- Diffuse Intrinsic Pontine Glioma
- +5 more
- Marizomib
- Panobinostat
-
Boston, Massachusetts
- +1 more
May 3, 2022
Medulloblastoma Trial in Houston (Treatment with MTX110)
Recruiting
- Medulloblastoma
- Treatment with MTX110
-
Houston, TexasThe University of Texas Health Science Center at Houston
Jun 30, 2022
Diffuse Intrinsic Pontine Glioma, Diffuse Pontine and Thalamic Gliomas, Diffuse Midline Glioma, H3 K27M-Mutant Trial in New York
Active, not recruiting
- Diffuse Intrinsic Pontine Glioma
- +2 more
- Panobinostat 15 MG
- Focused Ultrasound with neuro-navigator-controlled sonication
-
New York, New YorkColumbia University Irving Medical Center / NewYork-Presbyterian
Feb 3, 2022
Rhabdoid Tumor, Atypical Teratoid/Rhabdoid Tumor, Malignant Rhabdoid Tumor Trial in Australia, New Zealand, United States
Terminated
- Rhabdoid Tumor
- +3 more
- Panobinostat
-
Durham, North Carolina
- +10 more
Jun 5, 2022
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Seattle (Carfilzomib, Chemosensitivity Assay,
Terminated
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Carfilzomib
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
May 6, 2022
Multiple Myeloma Trial in United States (panobinostat, carfilzomib)
Plasma Cell Leukemia, Plasmacytoma, Recurrent Plasma Cell Myeloma Trial in Houston (procedure, drug, other)
Active, not recruiting
- Plasma Cell Leukemia
- +3 more
- Autologous Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
Clear Cell Renal Cell Carcinoma, Recurrent Renal Cell Cancer, Stage III Renal Cell Cancer Trial in Buffalo, Rochester
Terminated
- Clear Cell Renal Cell Carcinoma
- +3 more
- panobinostat
- +7 more
-
Buffalo, New York
- +1 more
Aug 11, 2022
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma Trial in
Completed
- Adult Nasal Type Extranodal NK/T-cell Lymphoma
- +20 more
- panobinostat
- +6 more
-
Scottsdale, Arizona
- +1 more
May 6, 2022
GVHD, GVHD Trial in Tampa (Panobinostat, Sirolimus, Tacrolimus)
Completed
- Graft Versus Host Disease
- GVHD
- Panobinostat
- +2 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Jul 19, 2021
Multiple Myeloma in Relapse Trial in Boston, Durham (Panobinostat, Dexamethasone, Lenalidomide)
Completed
- Multiple Myeloma in Relapse
- Panobinostat
- +3 more
-
Boston, Massachusetts
- +3 more
Sep 3, 2021
Metastatic Colorectal Cancer Trial in Oslo (Alectinib, Cetuximab, Crizotinib)
Recruiting
- Metastatic Colorectal Cancer
- Alectinib
- +16 more
-
Oslo, NorwayOslo University Hospital
Feb 10, 2023
Sickle Cell Disease Trial in Augusta (panobinostat)
Active, not recruiting
- Sickle Cell Disease
- panobinostat
-
Augusta, GeorgiaAugusta University
May 26, 2021
Acute Myeloid Leukaemia (AML), MDS (MDS) Trial in Germany, Netherlands (Panobinostat)
Active, not recruiting
- Acute Myeloid Leukaemia (AML)
- Myelodysplastic Syndromes (MDS)
- Panobinostat
-
Stuttgart, Baden-Württemberg, Germany
- +18 more
Dec 13, 2021
Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus (Bortezomib, Daratumumab and Hyaluronidase-fihj,
Recruiting
- Recurrent Plasma Cell Myeloma
- Refractory Plasma Cell Myeloma
- Bortezomib
- +3 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Nov 30, 2021
Primary Myelofibrosis, Post-Polycythemia Vera, Post-Essential Thrombocytopenia Trial in United States (Panobinostat)
Terminated
- Primary Myelofibrosis
- +2 more
- Panobinostat
-
Scottsdale, Arizona
- +8 more
Jul 9, 2021
Diffuse Intrinsic Pontine Glioma Trial in San Francisco (Panobinostat Nanoparticle Formulation MTX110, Convection-Enhanced
Completed
- Diffuse Intrinsic Pontine Glioma
- Panobinostat Nanoparticle Formulation MTX110
- Convection-Enhanced Delivery (CED)
-
San Francisco, CaliforniaUniversity of California, San Francisco
Feb 2, 2022
Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma Trial in
Completed
- Colorectal Cancer, Non-small Cell Lung Carcinoma (Adenocarcinoma), Triple Negative Breast Cancer, Renal Cell Carcinoma
- PDR001
- +5 more
-
Santa Monica, California
- +24 more
Mar 11, 2022
Idiopathic Myelofibrosis, Post Essential Thrombocythemia Myelofibrosis, Post Polycythemia-Vera Myelofibrosis Trial in Worldwide
Completed
- Idiopathic Myelofibrosis
- +2 more
- panobinostat
- ruxolitinib
-
Paris, France
- +9 more
Jun 22, 2021
Hodgkin's Lymphoma Trial in Houston (Panobinostat, Ifosfamide, Mesna)
Completed
- Hodgkin's Lymphoma
- Panobinostat
- +5 more
-
Houston, TexasUniversity of Texas MD Anderson Cancer Center
Dec 10, 2020
Advanced Solid Tumors Trial in Worldwide (panobinostat (LBH589))
Completed
- Advanced Solid Tumors
- panobinostat (LBH589)
-
Salt Lake City, Utah
- +4 more
Dec 16, 2020
Prostate Cancer Trial in Canada, United States (LBH589 (i.v. panobinostat))
Completed
- Prostate Cancer
- LBH589 (i.v. panobinostat)
-
Rockville, Maryland
- +8 more
Dec 16, 2020